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ABSTRACT Surfactant protein B (SP-B) is an essential component of pulmonary surfactant. Synthetic surfactant peptide 
KL4, a peptide based on a C-terminal amphipathic helical region of human SP-B, efficiently mimics some functional 
properties of SP-B and is included in therapeutic surfactant preparations currently used in trials to treat respiratory distress 
syndrome. The membrane orientation of this peptide is controversial. We used an in vitro transcription-translation system 
to study the insertion of hydrophobic sequences into microsomal membranes, and showed that the KL4 sequence 
integrates efficiently with a transmembrane orientation despite the presence of intermittent lysines throughout the 
sequence. In contrast, the precise sequence of the C-terminal SP-B amphipathic region failed to integrate, indicating a 
non-transmembrane orientation. Differences in the membrane insertion between KL4 and the SP-B inspiring sequence 
match predictions from calculated free energies of insertion of the two sequences into membranes. 
 
Pulmonary surfactant is a mixture of lipids and proteins 
that lowers surface tension at the air/liquid interface, 
thereby reducing the work involved in breathing and 
reducing the risk of collapse at expiration. The main lipid 
constituent and surface tension-reducing component is 
dipalmitoylphosphatidylcholine (DPPC) (2). DPPC, 
however, is extremely inefficient at adsorbing into the 
interface. Two small hydrophobic proteins, SP-B and SP-
C, facilitate the rapid movement of lipids between 
membranes and the interface and help re-spread the 
compressed state of the films during subsequent cycling 
(3). Surfactant membranes also contain anionic 
phosphatidylglycerol, which is thought to establish 
functionally important interactions with cationic SP-B and 
SP-C (4). 
Pulmonary surfactant is essential for survival, and its 
deficiency or dysfunction contributes to severe respiratory 
pathologies such as infant respiratory distress syndrome 
(IRDS) in neonates or acute respiratory distress syndrome 
(ARDS). Surfactant therapy using exogenous surfactants is 
currently a routine clinical procedure for the prevention 
and treatment of IRDS. The hydrophobic SP-B and SP-C 
proteins are essential components for the physiological 
activity of most clinical surfactants (5), which are currently 
obtained from animal sources. Because the use of animal 
derived surfactants bears serious concerns in terms of 
potential infections, immunological responses and 
compositional consistency, the development of synthetic 
surfactants is a topic of intense investigation (6). 
The structural complexity of SP-B has thus far precluded 
the expression of functionally active recombinant SP-B. 
However, synthetic surfactants that contain peptide mimics 
of SP-B segments have been developed (Surfaxin®), 
exhibiting some efficacy in cases of IRDS (7). The peptide 
included in this synthetic surfactant (KL4) was based on 
the C-terminal region of mature SP-B, a hydrophobic 
sequence with intermittent positively charged residues, 
which improved the interfacial activity of synthetic 
phospholipids (8). KL4 was designed as a similar sequence 
pattern of hydrophobic/cationic residues, consisting of a 
stretch of four hydrophobic leucines interspersed with 
cationic lysine to create a 21-residue sequence ([lysine-
(leucine)4]4-lysine). KL4 has been proposed to stabilize 
interfacial lipid layers via electrostatic interactions 
between the lysines and anionic head groups, and 
hydrophobic interactions between the leucines and the 
phospholipid acyl chains (9). Nevertheless, the real 
orientation of this synthetic peptide in surfactant 
membranes and films has been a topic of discussion. KL4 
exhibited a high α-helical content as studied by infrared 
and circular dichroism spectroscopies in the presence of 
micelles or bilayers, and exhibited an orientation parallel to 
the lipid acyl chains in bilayers (10). In contrast, infrared 
reflection-absortion spectroscopy studies showed an 
antiparallel β-sheet structure of KL4 in interfacial films 
with a transition toward an α-helical conformation in the 
interfacial region of multilayers formed under compression 
(11). Conformation and lipid-protein interactions of KL4 
depend on membrane lipid composition, bilayer packing 
density and peptide concentration in the membrane 
(12,13). Thus, further studies are needed to determine the 
exact secondary structure and orientation of KL4 in 
biological membranes. This study examined the ability of 
the KL4 peptide sequence to integrate into endoplasmic 
reticulum (ER) membranes and compared its behaviour 
with that of the SP-B sequence that inspired its design. 
The membrane insertion capacity of the surfactant KL4 
peptide was investigated using an experimental system 
based on the Escherichia coli inner membrane protein 
leader peptidase (Lep), which accurately reports the 
integration of transmembrane (TM) helices into ER 
membranes (14). Lep consists of two TM segments 
connected by a cytoplasmic loop (P1) and a large C-
terminal domain (P2), and inserts into ER-derived 
microsomal membranes (MMs) with both termini located 
in the lumen (Fig. 1A). The segment analyzed (H-segment) 
is engineered into the luminal P2 domain and is flanked by 
two acceptor sites (G1 and G2) for N-linked glycosylation. 
Single glycosylation (i.e., membrane integration) results in 
a molecular mass increase of approximately 2.5 kDa 
relative to the observed molecular mass of Lep expressed 
in the absence of microsomes; the molecular mass shifted 
approximately 5 kDa upon double glycosylation (i.e., 
membrane translocation of the H-segment). Proteinase K 
 2 
(PK) added to MM vesicles will digests the cytoplasmic 
exposed, non-glycosylated form of the P2 domain (Fig. 
1A, left) to produce a protected, double-glycosylated P2 
fragment when the P2 domain is located in the lumen of 
the MMs (Fig. 1A, right). 
Given the amino acid sequence of an H-segment, TM 
orientation can be predicted using the apparent free energy 
difference (ΔGapp) for insertion into ER membranes (15). 
The predicted ΔGapp for the KL4 sequence was computed 
as -2.14 kcal/mol (Fig. 1C, calculated using the ΔG 
Prediction Server v1.0, http://www.cbr.su.se/DGpred/) 
(14,15). The negative ΔGapp predicts the KL4 sequence as a 
TM segment, resembling the TM orientation of surfactant 
protein SP-C rather than SP-B in terms of ER membrane 
integration. In fact, sequence 13-35 of SP-C (Fig. 1B) is 
predicted to be TM (Fig. 1C), while the SP-B segment that 
inspired KL4 (segment 59-79; Figure 1B) is predicted to 
not be integrated into membranes (Fig. 1C). 
The translation of constructs harbouring the KL4 
sequence (constructed using double-stranded 
oligonucleotides as previously described (16)) clearly 
resulted in single glycosylated forms (Fig. 1D, lane 2). 
Proteinase K treatment of this sample rendered complete 
loss of detectable fragments (Fig. 1D, lane 3), confirming 
membrane integration of the KL4 sequence. The dispersion 
of charged lysine residues in the KL4 sequence around the 
circumference of the helix (Fig. 1E, left) has been argued 
to inhibit partition of the peptide into the core of the 
bilayer (11). Nevertheless, the strong hydrophobic 
contribution of the abundant leucine residues in KL4 may 
reduce the free energy of membrane integration. 
Interestingly, recent computer simulation studies suggest 
that the transfer of approximately 4 leucines from water to 
the bilayer interior could be sufficient to balance the 
transfer of a cationic residue (17). Translation of a 
construct bearing the TM segment of SP-C in the presence 
of MMs yielded single-glycosylated forms sensitive to 
proteinase K digestion (Fig. 1D, lanes 5 and 6), indicative 
of TM integration. We also examined the SP-B 59-79 
sequence. As shown in Fig. 1D (lanes 7-9), translation of 
this construct in the presence of MMs rendered double-
glycosylated forms (lane 8), and proteinase K treatment of 
this sample generated a protected double-glycosylated P2 
fragment (lane 9), indicating membrane translocation of 
this H-segment. 
One possibility is that the particular chemical character 
of lysine residues may be important for the membrane 
integration process of TM segments. To test this idea, we 
replaced the central lysine residue in KL4 with either 
aspartic acid or arginine. As shown in Fig. 2, both 
sequences inserted in the membrane in a manner similar to 
KL4 (lanes 2-4) in good agreement with computed values, 
arguing against specific effects of the lysine itself. 
Furthermore, insertion of a second lysine in the central 
region of the KL4 sequence, which reduced the predicted 
ΔGapp by 1.62 kcal/mol (Fig. 2), retained insertion of ~85% 
of the molecules (Fig. 2, lane 5). 
As stated, some controversy surrounds the actual 
orientation of KL4 peptide in surfactant membranes and 
films (18,19). Despite the fact that this peptide was 
originally designed to mimic amphipathic peripheral 
helices in SP-B, significant structural differences exist 
between KL4 and the C-terminal amphipathic helices of 
SP-B. In fact, a model of the SP-B 63-78 residue region 
based on the structure of Mini-B (a minimized version of 
the SP-B protein, PDB code: 2DWF) (20) shows a non-
canonical helix conformation with an amphipathic 
distribution of the cationic residues (Fig. 1E, right), which 
can account for the non-integration effect observed in our 
experimental system. 
The present work shows that KL4 adopts a TM 
orientation in MMs, and therefore can hardly be considered 
Figure 1. (A) Schematic of the engineered leader peptidase 
(Lep) model protein. (B) The H-segment sequences examined in 
this study. (C) Calculated ΔGapp values for the assessed 
sequences using the ΔG Prediction Server (see text). (D) In vitro 
translation in the presence (+) or absence (–) of MMs and 
proteinase K (PK). Non-glycosylated protein bands are indicated 
by a white dot; single and double glycosylated proteins are 
indicated by one and two black dots, respectively. The protected 
double-glycosylated P2 fragment is indicated by an asterisk (*). 
(E) Left: KL4 canonical helix structure. Center: SP-C helical 
region (residues 13-35) from the structure determined by NMR 
(PDB: 1SPF) (1). Right: SP-B region (residues 63-78) based on 
the structure of Mini-B in SDS micelles (PDB code: 2DWF). Side 
chains of Arg and Lys residues are shown. 
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as an analog of surfactant protein SP-B. However, as a TM 
peptide, KL4 could still efficiently promote the transfer of 
phospholipids from bilayers into interfacial films, similar 
to SP-C (21). Whether KL4 could be actually transferred 
into the interface upon adsorption of peptide/lipid 
complexes remains to be demonstrated. Most studies have 
characterized the interfacial behaviour of SP-C or KL4 in 
films formed from lipid/peptide organic mixtures, which 
may not entirely reflect their behaviour when films are 
formed from lipid/peptide aqueous suspensions. SP-B has 
been suggested to have an active role in stabilizing 
compressed interfacial structures, contributing to reach the 
lowest tensions required to stabilize respiratory mechanics 
(22). The structure of KL4 was proposed to mimic the 
electrostatic and hydrophobic interactions associated with 
high mechanical stability in SP-B-containing films (9). Our 
results suggest that the analogy between the behaviour of 
KL4 and SP-B at the interface has yet to be demonstrated, 
particularly in films formed from lipid/protein structures in 
which the two polypeptides could have very different 
orientations. Further studies will explore the minimal 
sequence variations required for KL4-like peptides to 
mimic the orientation of SP-B sequences with respect to 
membranes and the dependence of parameters defining 
optimal surfactant activity on specific peptide-membrane 
orientations.  
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Figure 2. Polar residues at the central position of KL4 
sequence. Bands of non-, single- and double-glycosylated 
proteins are indicated as in Fig. 1. The H-segment sequence in 
each construct is shown on the bottom with polar residues in 
bold, together with their predicted ΔGapp values. 
